I et af disse forsøg, et forsøg med fast dosis, sås signifikant dosis- responsforhold for cerebrovaskulære bivirkninger hos aripiprazol- behandlede patienter.
However, in one of these trials, a fixed-dose trial, there was a significant dose response relationship for cerebrovascular adverse events in patients treated with aripiprazole.